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A simple and environmentally friendly microextraction technique was used for determination of 
chlorpheniramine (CPM), an antihistamine drug, in human urine samples using dispersive liquid–liquid 
microextraction (DLLME) followed by high performance liquid chromatography with diode array 
detection (HPLC-DAD). In this extraction technique, an appropriate mixture of acetonitrile (disperser 
solvent) and carbon tetrachloride (extraction solvent) was rapidly injected into the urine sample containing 
the target analyte. Tiny droplets of extractant were formed and dispersed into the sample solution and 
then sedimented at the bottom of the conical test tube by centrifugation. Under optimal conditions, the 
calibration curve was linear in the range of 0.055-5.5 µg mL-1, with a detection limit of 16.5 ng mL-1. 
This proposed method was successfully applied to the analysis of real urine samples. Low consumption 
of toxic organic solvents, simplicity of operation, low cost and acceptable figures of merit are the main 
advantages of the proposed technique.
Uniterms: Chlorpheniramine/determination in human urine. High-performance liquid chromatography/
quantitative analysis. Dispersive liquid-liquid microextraction/quantitative analyisis. Antihistamines. 
Human urine/analysis.
Utilizou-se uma técnica de microextração simples e ambientalmente amigável para a determinação de 
clorfeniramina (CPM), anti-histamínico, em amostras de urina humana, utilizando a microextração 
dispersiva líquido-líquido (DLLME), seguida por cromatografia líquida de alta eficiência com detecção por 
arranjo de diodos (HPLC-DAD). Nesse método de extração, mistura apropriada de acetonitrila (solvente 
dispersor) e tetracloreto de carbono (solvente de extração) foi injetada rapidamente na amostra de urina 
contendo o analito alvo. As pequenas gotículas de agente de extração foram formadas e dispersas na 
solução da amostra e, em seguida, sedimentadas no fundo do tubo cônico de ensaio por centrifugação. 
Em condições ótimas, a curva de calibração foi linear no intervalo entre 0,055 e 5,5 µg mL-1, com limite 
de detecção de 16,5 ng mL-1. O método proposto foi aplicado com sucesso na análise de amostras de 
urina reais. Baixo consumo de solventes orgânicos tóxicos, simplicidade de operação, baixo custo e 
figuras de mérito aceitáveis são as principais vantagens do método sugerido.
Unitermos: Clorfeniramina/determinação na urina humana. Cromatografia líquida de alta eficiência/
análise quantitativa. Microextração dispersiva líquido-líquido/análise quantitativa. Anti-histamínicos. 
Urina humana/análise.
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INTRODUCTION
Chlorpheniramine (CPM, [3-(p-chlorophenyl)-3-(2-
pyridyl)-N,N-dimethylpropylamine]) is a histamine H1-
receptor antagonist, which is often found as an ingredient 
of ‘over-the counter’ treatments to alleviate symptoms 
of the common cold and allergic conditions (Fried et al., 
2002). In the World Health Organization standards, CPM 
is considered as an essential drug due to its effectiveness 
and low cost. Therefore, it is distributed worldwide as a 
generic compound (Hiep et al., 1998). Methods for the 
analysis of the CPM from human samples (such as urine) 
are required for kinetic studies, diagnosis and effective 
treatment of the poisoning and for forensic purposes 
(Baker, Borys, 2002; Hasegawa et al., 2006).
Sample pretreatment is the most labor-intensive and 
time-consuming step in an analytical method. Traditional 
methods such as liquid–liquid extraction (LLE) and solid 
phase extraction (SPE) have been widely used as sample 
preparation methods for extraction and preconcentration 
of analytes (Benjamin, Xiaochen, 2007; Zhu et al., 2011). 
These methods are time consuming, tedious, relatively 
expensive and use large amounts of sample and toxic 
organic solvents and thus produce high secondary wastes. 
To overcome these disadvantages, miniaturization and 
expansion of environmentally extraction methods have 
been considered by many researchers in the past decades. 
Liquid-phase microextraction (LPME), a miniaturization 
of the liquid–liquid extraction, was introduced by Cantwell 
and co-workers (Jeannot, Cantwell, 1996). Several LPME 
techniques such as single drop microextraction (SDME) 
(Alothman et al., 2012), solvent bar microextraction 
(SBME) (Kamarei, Ebrahimzadeh, Yamini, 2010), hollow 
fiber-LPME (HF-LPME) (Lee et al., 2008; Ebrahimzadeh 
et al., 2012) and liquid–liquid–liquid microextraction 
(LLLME) (Lin, Fuh, Huang, 2011; Gao et al., 2012) have 
been developed. Furthermore, Dispersive liquid–liquid 
microextraction (DLLME) has been introduced as a novel 
LPME by Assadi research group (Rezaee et al., 2006). In 
the latter technique, a suitable mixture of extraction and 
disperser solvents is rapidly injected into the aqueous 
sample by a syringe. A cloudy solution then results from 
the formation of tiny droplets of the extraction solvent. 
After extraction, the enriched droplets of extractant in the 
sample solution are collected at the bottom of the conical 
test tube by centrifugation. Determination of analyte in 
the sediment phase can be accomplished by instrumental 
techniques (Ezoddin, Shemirani, Jamali, 2010; Kazemi, 
Shokoufi, Shemirani, 2011).
Our research group has developed DLLME for 
the extraction and pre-concentration of some organic 
compounds in different food and biological samples 
(Karami-Osboo et al., 2013; Maham et al., 2013a,b,c). In 
the present study, we used DLLME-HPLC technique for 
determination of CPM in human urine samples. Significant 
parameters, which influence the efficiency of the system 
were investigated and optimized in detail.
EXPERIMENTAL
Apparatus
HPLC analysis was performed using a Waters HPLC 
system equipped with two 515 pumps and a photodiode 
array detector (Waters, USA). The analytical column 
was packed with C8 stationary phase (250 × 4.6 mm I.D., 
particle size 5 µm). The mobile phase used for the analysis 
consisted of a mixture of ammonium acetate (0.03 M, 
pH=5.5) and acetonitrile (50:50 v/v) at a flow rate of 
1 mL min-1 
Reagents
Solvents used for chromatography were of HPLC 
grade and the other chemicals were of analytical grade 
and obtained from Merck Chemical Co (Germany). 
CPM was purchased from United States Pharmacopeia 
(USP). A stock solution containing 10 mg L-1 of CPM 
was prepared by dissolving the appropriate amount of 
the corresponding pure salt in acetonitrile and stored at 4 
oC. Working solutions were prepared by serial spiking of 
drug free urine samples with the standard solution. Drug 
free urine samples were collected from healthy adults 
not exposed to any drug for at least 2 months. Real urine 
samples were collected from patient under treatment after 
12 h after administration of a single oral dose of CPM.
Sample preparation
The amount of 10 mL of urine was spiked with CPM 
and basified using sodium hydroxide. After centrifuging 
for 10 min at 4000 rpm, a white solid lipid was sedimented 
at the bottom of the conical test tube, probably due to 
the co-sedimentation of matrixes (such as urea and uric 
acid) in urine at high pH values. A 5 mL aliquot of the 
supernatant solution was used for DLLME.
Dispersive liquid–liquid microextraction 
procedure
The experimental procedure for suggested DLLME 
was as follows:
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(1)  A 5 mL aliquot of the pretreated urine sample was 
placed in a 10 mL test tube.
(2)  After rapidly injection of 0.6 mL acetonitrile (dis-
perser solvent) containing 30 µL carbon tetrachlo-
ride (extraction solvent) into the urine sample using 
a 1.00 mL syringe, a cloudy state was formed in the 
conical test tube.
(3)  The solution was centrifuged for 10 min at 4000 rpm. 
Subsequently, the dispersed fine droplets of carbon 
tetrachloride deposited in the conical bottom test 
tube along with whitish matrixes.
(4)  After removing the whole aqueous solution, the sedi-
mented phase was dissolved in 300 µL acetonitrile, fil-
trated through a 0.45 µm membrane and finally 20 µL 
of the extract was injected into an HPLC system.
RESULTS AND DISCUSSION
Selection of extraction solvent
In order to obtain maximum extraction efficiency, 
some important parameters such as extraction solvent type 
must be investigated in detail. In conventional DLLME, 
the extraction solvent should have a higher density than 
water to be collected at the bottom of the test tube after 
centrifuging. Also, the extraction solvent must have 
excellent extraction ability for target analyte and low 
solubility in the aqueous sample. In this study, a series of 
sample solutions were studied by using 0.6 mL acetonitrile 
containing 20 µL different extraction solvents such as 
carbon tetrachloride, chlorobenzene and dichloromethane. 
Laboratory observations showed that a two-phase system 
was not observed when dichloromethane was used as the 
extractant due to its high solubility in aqueous solution 
(Daneshfar, Khezeli, Lotfi, 2009). According to the 
experimental results (Figure 1), carbon tetrachloride had 
the best extraction efficiency for CPM. Therefore, carbon 
tetrachloride was selected as the extraction solvent in the 
subsequent experiments.
Selection of disperser solvent
The disperser solvent is used in DLLME to allow 
the formation of fine droplets of extraction solvent, which 
increases the mass transfer of the analyte as a result of the 
improved liquid–liquid interface. The disperser solvent 
must be miscible in the organic (extraction solvent) 
and aqueous phases (sample solution). Thus, the effects 
of acetone, methanol, acetonitrile, and ethanol on the 
extraction efficiency of CPM were studied. The results 
shown in Figure 2 indicate that the best performance for 
FIGURE 1 - Effect of extraction solvent type on the extraction 
efficiency. Conditions: CPM concentration: 0.5 µg mL-1; 
volume of extraction solvents: 20 µL; disperser solvent, volume: 
acetonitrile, 0.6 mL; pH value: 10; no salt addition. [N.A.: not 
applicable (extraction solvent was not separated from sample 
solution after centrifuging)].
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extraction of CPM in urine samples is obtained when 
acetonitrile is used as the disperser solvent. Acetonitrile 
was chosen for further experiments.
Effect of extraction solvent volume
During DLLME process, the extraction solvent 
volume is an essential factor influencing the formation 
of droplets after centrifuging. For optimization purposes, 
various experiments were performed using 0.6 mL 
acetonitrile containing different volumes of carbon 
tetrachloride (10, 20, 30 and 40 µL). As shown in Figure 
3, the best sensitivity was obtained when 30 µL carbon 
tetrachloride and 0.6 mL acetonitrile were used. The 
optimal result can be attributed to the best volume ratio 
between the disperser and the extraction solvents to form 
a stable cloudy solution.
FIGURE 2 - Effect of disperser solvent type on the extraction 
efficiency. Conditions: CPM concentration: 0.5 µg mL-1; 
extraction solvent, volume: carbon tetrachloride, 20 µL; volume 
of disperser solvents: 0.6 mL; pH value: 10; no salt addition.
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Effect of disperser solvent volume
In order to study the effect of acetonitrile volume on 
the extraction efficiency, different volumes of acetonitrile 
in the range of 0.25-1.2 mL were investigated. As shown 
in Figure 4, the results show that by increasing the 
volume of acetonitrile in the range of 0.25-0.6 mL, the 
extraction efficiency gradually increased, whereas at 
volumes higher than 0.6 mL, the extraction efficiency 
decreased for CPM. This decrease in the extraction 
performance may be related to the increase in solubility 
of the target analyte in aqueous sample. Based on the 
optimal results, 0.6 mL acetonitrile was considered for 
subsequent experiments.
Effect of the pH
The effect of pH in the range of 2-12 was investigated. 
The results, as shown in Figure 5, indicate that pH is 
a critical factor, which significantly affects extraction 
efficiency of CPM. For CPM, as a basic analyte (pKa = 9.2) 
(Capella-Peiró, Bossi, Esteve-Romero, 2006), the ionized 
form of analyte changed mostly to molecular form when 
the pH of the sample solution was greater than pKa value of 
the analyte. Under this condition, target analyte was easily 
extracted into the organic phase. According to the results 
obtained, the best extraction efficiency was achieved at 
pH value of 10.
Effect of salt
Generally, salt addition decreases the solubility 
of target analyte in the aqueous phase and increases its 
partitioning into the adsorbent (for SPME) or organic 
phase (LPME). To evaluate the effect of salt addition on 
the extraction efficiency, a series of sample solutions was 
studied by using different concentrations of NaCl over the 
range of 0-15% (w/v), while other experimental conditions 
were kept constant. The results obtained revealed that 
the maximum extraction efficiency was achieved in the 
presence of 7.5% NaCl (Figure 6). The gradual increase in 
the extraction efficiency, at concentrations of 0-7.5% (w/v) 
NaCl, was attributed to the decreased in the concentration 
of water available to dissolve the analyte molecules, which 
decreases the solubility of the target analyte in the aqueous 
phase. Decrease in extraction efficiency at concentrations of 
NaCl over 7.5% may be related to the increase in viscosity 
of the solution, and thus the decrease in the diffusion rate of 
the target analyte into the extraction solvent. Hence, 7.5% 
salt was added in the following experiments.
Method validation
The optimal conditions were chosen as follows: 
30.0 µL carbon tetrachloride (extraction solvent), 0.6 mL 
FIGURE 4 - Effect of the volume of disperser solvent on the 
extraction efficiency. Conditions: CPM concentration: 0.5 µg mL-1; 
extraction solvent, volume: carbon tetrachloride, 30 µL; disperser 
solvent: acetonitrile; pH value: 10; no salt addition.
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FIGURE 5 - Effect of the pH values on the extraction efficiency. 
Conditions: CPM concentration: 0.5 µg mL-1; extraction solvent, 
volume: carbon tetrachloride, 30 µL; disperser solvent, volume: 
acetonitrile, 0.6 mL; no salt addition.
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FIGURE 3 - Effect of the volume of extraction solvent on the 
extraction efficiency. Conditions: CPM concentration: 0.5 µg mL-1; 
extraction solvent: carbon tetrachloride; disperser solvent, 
volume: acetonitrile, 0.6 mL; pH value: 10; no salt addition.
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TABLE I - Analytical performance characteristics of the DLLME-HPLC/DAD method for CPM determination under the optimum 
conditions
Linear range (µg mL-1) 0.055-5.5
Limit of detection (ng mL-1) 16.5
Limit of quantification (ng mL-1) 55.2
Precision (RSD, n = 5) (%) 5.2
Enrichment factor 26.4
Curve equation (with pre-concentration) Y= 150692x + 108.48 R2= 0.9984
Curve equation (without pre-concentration) Y= 5695.3x + 270.97 R2= 0.9996
TABLE II - Relative recoveries of CPM spiked 3-level concentrations in patient urine samples under treatment*
Antihistamine Initial concentration mean ± SD** (µg mL-1)
Concentration 
added (µg mL-1)
Concentration 
determined mean ± 
SD** (µg mL-1)
Relative standard 
deviation (%)
Relative recovery 
(%)
CPM 0.096 ± 0.005 0.08 0.183 ± 0.007 3.82 107.4
0.12 0.223 ± 0.007 3.13 103.6
0.18 0.267 ± 0.009 3.37 98.5
*Extraction conditions: extraction solvent, volume: carbon tetrachloride, 30 µL; disperser solvent, volume: acetonitrile, 0.6 mL; 
pH value 10; ionic strength: 7.5%. **SD, standard deviation (n=3)
FIGURE 6 - Effect of the salt addition on the extraction efficiency. 
Conditions: CPM concentration: 0.5 µg mL-1; extraction solvent, 
volume: carbon tetrachloride, 30 µL; disperser solvent, volume: 
acetonitrile, 0.6 mL; pH=10.
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acetonitrile (disperser solvent), pH=10 and 7.5% salt 
addition. A series of drug free urine samples spiked with 
different concentrations of CPM were prepared and 
extracted under the optimal conditions. The analytical 
performance are summarized in Table I. Linearity of 
calibration curve was observed in the concentration range 
of 0.055-5.5 µg mL-1 with a correlation coefficient of 
0.9984. The limit of detection (LOD), based on signal-
to-noise ratio (S/N) of 3, and the limit of quantification 
(LOQ), based on signal-to-noise ratio (S/N) of 10, were 
16.5 and 55.2 ng mL-1, respectively. The repeatability of 
the method presented as the relative standard deviation 
(RSD) was 5.2% for five replicated measurements at 
0.5 μg mL-1 of CPM. The enrichment factor, defined as 
ratio of calibration curve slope with and without pre-
concentration, was 26.4.
Application of the technique
In order to evaluate the influence of matrix, the 
optimized procedure was applied for the determination 
of CPM in real urine samples obtained from patient under 
treatment. The results showed that the concentration of 
target analyte in the patient urine samples was 0.096 ± 
0.005 µg mL-1. These samples were then spiked with 
CPM standard at three different levels and analyzed by 
the suggested method. The results of relative recoveries 
of CPM (Table II) were in the range of 98.5%–107.4%, 
demonstrating that the drug and its metabolites with 
endogenous major components in urine samples had no 
significant effect on the performance of the proposed 
method.
CONCLUSION
This paper describes the application of the DLLME 
method combined with HPLC-DAD, for determination 
of trace amounts of CPM in human urine samples. The 
method provides a good repeatability, suitable enrichment 
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factor and low detection limit. The proposed technique 
has several benefits as compared to conventional sample 
preparation methods such as simplicity of operation, low 
cost and consumption of very low volumes of toxic organic 
solvents. In addition, putting all the advantages together, 
DLLME possesses great potential for the analysis of 
different classes of drugs in urine samples.
REFERENCES
ALOTHMAN, Z.A.; DAWOD, M.; KIM, J.; CHUNG, D.S. 
Single-drop microextraction as a powerful pretreatment tool 
for capillary electrophoresis: a review. Anal. Chim. Acta., 
v.739, p.14-24, 2012.
BAKER, S.D.; BORYS, D.J. A possible trend suggesting 
increased abuse from Coricidin exposures reported to the 
Texas Poison Network: comparing 1998 to 1999. Vet. Hum. 
Toxicol., v.44, p.169-71, 2002.
BENJAMIN, R.C.; XIAOCHEN, G. Quantification of 
antihistamine acrivastine in plasma by solid-phase 
extraction and high-performance liquid chromatography. 
J. Pharm. Biomed. Anal., v.43, p.293-297, 2007.
CAPELLA -PEIRÓ, M.E.; BOSSI, A.; ESTEVE -ROMERO, 
J. Optimization by factorial design of a capillary zone 
electrophoresis method for the simultaneous separation of 
antihistamines. Anal. Biochem., v.352, p.41-49, 2006.
DANESHFAR, A.; KHEZELI, T.; LOTFI, H.J. Determination 
of cholesterol in food samples using dispersive liquid–liquid 
microextraction followed by HPLC–UV. J. Chromatogr. B, 
v.877, p.456-460, 2009.
EBRAHIMZADEH, H.; SHEKARI, N.; SAHARKHIZ, Z.; 
ASGHARINEZHAD, A.A. Simultaneous determination 
of chloropheniramine maleate and dextromethorphan 
hydrobromide in plasma sample by hollow fiber liquid 
phase microextraction and high performance liquid 
chromatography with the aid of chemometrics. Talanta, 
v.94, p.77-83, 2012.
EZODDIN, M.; SHEMIRANI, F.; JAMALI, M.R. Fiber 
optic-linear array detection spectrophotometry in 
combination with dispersive liquid-liquid microextraction 
for preconcentration and determination of copper. J. Anal. 
Chem., v.65, p.153-158, 2010.
FRIED, K.M.; YOUNG , A.E.; YASUDA, S.U.; WAINER, I.W. 
The enantioselective determination of chlorpheniramine 
and its major metabolites in human plasma using chiral 
chromatography on a β-cyclodextrin chiral stationary phase 
and mass spectrometric detection. J. Pharm. Biomed. Anal., 
v.27, p.479-485, 2002.
GAO, W.; CHEN, Y.; CHEN, G; Xi, J.; CHEN, Y.; YANG, 
J.; Xu, N. Trace analysis of three antihistamines in 
human urine by on-line single drop liquid–liquid–liquid 
microextraction coupled to sweeping micellar electrokinetic 
chromatography and its application to pharmacokinetic 
study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 
v.904, p.121-127, 2012.
HASEGAWA, C.; KUMAZAWA, T.; LEE, X.P.; FUJISHIRO, 
M.; KURIKI, A.; MARUMO, A.; SENO, H.; SATO, K. 
Simultaneous determination of ten antihistamine drugs in 
human plasma using pipette tip solid-phase extraction and 
gas chromatography/mass spectrometry. Rapid. Commun. 
Mass. Spectrom., v.20, p.537-543, 2006.
HIEP, B.T.; KHANH, V.; HUNG, N.K.; THUILLIER, A.; 
GIMENEZ, F. Determination of the enantiomers of 
chlorpheniramine and its main monodesmethyl metabolite 
in urine using achiral-chiral liquid chromatography. J. 
Chromatogr. B: Biomed. Sci. Appl., v.707, p.235-240, 1998.
JEANNOT, M.A.; CANTWELL, F.F. Solvent microextraction 
into a single drop. Anal. Chem., v.68, p.2236-2240, 1996.
KAMAREI, F.;  EBRAHIMZADEH, H.;  YAMINI, Y. 
Optimization of solvent bar microextraction combined with 
gas chromatography for the analysis of aliphatic amines in 
water samples. J. Hazard. Mater., v.178, p.747-752, 2010.
KARAMI-OSBOO, R.; MAHAM, M.; MIRI, R.; SHOJAEE 
ALIABADI, M.H.; MIRABOLFATHY, M.; JAVIDNIA, 
K. Evaluation of dispersive liquid–liquid microextraction–
HPLC–UV for determination of deoxynivalenol (DON) in 
wheat flour. Food Anal. Methods, v.6, p.176-180, 2013.
KAZEMI, E.; SHOKOUFI, N.; SHEMIRANI, F. Indium 
determination and preconcentration using fiber optic linear 
array detection spectrometry combined with dispersive 
liquid-liquid micro extraction. J. Anal. Chem., v.66, p.924-
929, 2011.
Analysis of chlorpheniramine in human urine samples using dispersive liquid–liquid microextraction 557
LEE, J.; LEE, H.K.; RASMUSEN, K.E.; PEDERSEN-
BJERGARD, S. Environmental and bioanalytical 
applications of hollow fiber membrane liquid-phase 
microextraction: a review. Anal. Chim. Acta, v.624, p.253-
268, 2008.
LIN, C.Y.; FUH, M.R.; HUANG, S.D. Application of liquid–
liquid–liquid microextraction and high-performance liquid 
chromatography for the determination of alkylphenols and 
bisphenol-A in water. J. Sep. Sci., v.34, p.428-435, 2011.
MAHAM, M.; KARAMI-OSBOO, R.; KIAROSTAMI, V.; 
WAQIF-HUSAIN, S. Novel binary solvents-dispersive 
liquid-liquid microextraction (BS-DLLME) method 
for determination of patulin in apple juice using high-
performance liquid chromatography. Food Anal. Methods, 
v.6, p.761-766, 2013a.
MAHAM, M.; KIAROSTAMI, V.; WAQIF-HUSAIN, 
S.; ABROOMAND-AZAR, P.; SABER-TEHRANI, 
M.; KHOEINI-SHARIFABADI, M.; AFROOZI, H.; 
SHAPOURI, M.R.; KARAMI-OSBOO, R. Extraction 
and determination of cyproheptadine in human urine by 
DLLME-HPLC method. Iran. J. Pharm. Res., v.12, p.311-
318, 2013b.
MAHAM, M.; KIAROSTAMI, V.; WAQIF-HUSAIN, 
S.; KARAMI-OSBOO, R.; MIRABOLFATHY, M. 
Analysis of ochratoxin A in malt beverage samples using 
dispersive liquid-liquid microextraction coupled with liquid 
chromatography-fluorescence detection. Czech J. Food Sci., 
v.31, p.520-525, 2013c.
REZAEE, M.; ASSADI, Y.; MILANI HOSSEINI, M.R.; 
AGHAEE, E.; AHMADI, F.; BERIJANI, S. Determination 
of organic compounds in water using dispersive liquid–
liquid microextraction. J. Chromatogr. A, v.1116, p.1-9, 
2006.
ZHU, Y.R.; JIA, Y.Y.; JIANG, L.; WANG, C.; DING, L.K.; 
YANG, J.; LI, L.; ZHAO, P.X.; LIU, W.X.; DING, Y.; 
WANG, L.; WEN, A.D. Determination of azatadine in 
human plasma by liquid chromatography/tandem mass 
spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. 
Life Sci., v.879, p.2189-2193, 2011.
Received for publication on 18th July 2013
Accepted for publication on 20th January 2014

